Clinical and Radiological Outcomes of Medacta Shoulder System

Launched by MEDACTA INTERNATIONAL SA · Jun 5, 2018

Keywords

ClinConnect Summary

The clinical trial titled "Clinical and Radiological Outcomes of Medacta Shoulder System" is looking at the effectiveness and safety of a specific shoulder replacement system called the Medacta Shoulder System. This study is focused on patients who have various shoulder conditions such as arthritis, rotator cuff tears, or have previously had shoulder surgery. The trial is currently recruiting participants aged 18 and older, and it welcomes individuals of all genders.

To be eligible for this study, patients must have one of the specified shoulder conditions and should not have serious infections or cancers at the time of surgery. Participants can expect to undergo a shoulder replacement procedure and will be monitored afterward to see how well the new shoulder system works for them. This trial not only aims to improve patient care but also helps gather important information about the Medacta Shoulder System's long-term outcomes. If you or someone you know is considering shoulder surgery and fits the eligibility criteria, this trial could be a valuable opportunity to learn more about the treatment options available.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients older than 18 years
• * Patient with one of the following diagnosis:
• • Primary osteoarthritis Secondary osteoarthritis Cuff tear arthropathy; insufficient rotator cuff Acute fracture (\<21d) Rheumatoid or inflammatory arthritis Avascular necrosis Other posttraumatic condition Revision of shoulder arthroplasty
• Exclusion Criteria:
• • Patients with malignant diseases (at the time of surgery)
• • Patients with proven or suspect infections (at the time of surgery)
• • Patients with functional deficits other than dysfunction of the shoulder (at the time of surgery)
• • Patients with known incompatibility or allergy to products materials (at the time of surgery)